Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

被引：0
|
作者：
Laurent Kodjikian
Lluís Arias Barquet
András Papp
Peter J. Kertes
Edoardo Midena
Jan Ernest
Rufino Silva
Thomas Schmelter
Tobias Niesen
Sergio Leal
机构：
[1] Croix-Rousse Teaching Hospital,Department of Ophthalmology
[2] Hospices Civils de Lyon,UMR
[3] Université Claude Bernard Lyon 1,CNRS 5510 Matéis, Villeurbanne
[4] University of Lyon,Department of Ophthalmology
[5] Hospital Universitario de Bellvitge,Department of Ophthalmology
[6] University of Barcelona,Department of Ophthalmology
[7] Semmelweis University,Department of Ophthalmology and Vision Sciences
[8] The John and Liz Tory Eye Centre,Department of Ophthalmology
[9] Sunnybrook Health Sciences Centre,Coimbra Institute for Clinical and Biomedical Research Faculty of Medicine (iCBR
[10] University of Toronto,FMUC)
[11] University Hospital,Ophthalmology Department
[12] Axon Clinical Research Center,undefined
[13] University of Coimbra,undefined
[14] Centro Hospitalar e Universitário de Coimbra (CHUC),undefined
[15] Association for Innovation and Biomedical Research on Light and Image (AIBILI),undefined
[16] Clinical Academic Center of Coimbra (CACC),undefined
[17] Bayer AG,undefined
[18] Bayer Consumer Care AG,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Anatomic outcomes; Anti-vascular endothelial growth factor; Fixed dosing; Functional outcomes; Intravitreal aflibercept; Neovascular age-related macular degeneration; Treat-and-extend; Treatment burden; Treatment interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1010 / 1024
页数：14
相关论文
共 50 条
  • [11] Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial
    Hatz, Katja B.
    Pruente, Christian
    Binningen, Vistaklinik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [12] Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a "Treat-and-Extend" Regimen
    Traine, Peter G.
    Pfister, Isabel B.
    Zandi, Souska
    Spindler, Jan
    Garweg, Justus G.
    OPHTHALMOLOGY RETINA, 2019, 3 (05): : 393 - 399
  • [13] Four-year outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a treat-and-extend regimen in Japanese patients
    Ishibashi, Koki
    Haruta, Masatoshi
    Ishibashi, Yumi
    Noda, Rie
    Dake, Shotaro
    Yoshida, Shigeo
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [14] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
  • [15] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    N Homer
    D S Grewal
    R G Mirza
    A T Lyon
    M K Gill
    Eye, 2015, 29 : 1152 - 1155
  • [16] Four-year results of a Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration
    Yoshida, Shigeo
    Umeno, Yumi
    Noda, Rie
    Ishibashi, Kouki
    Dake, Shoutarou
    Haruta, Masatoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [17] Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
    Homer, N.
    Grewal, D. S.
    Mirza, R. G.
    Lyon, A. T.
    Gill, M. K.
    EYE, 2015, 29 (09) : 1152 - 1155
  • [18] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial REPLY
    Decroos, Francis Char
    Reed, David
    Adam, Murtaza K.
    Salz, David
    Gupta, Omesh P.
    Ho, Allen C.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 182 : 205 - 206
  • [19] One-year results of intravitreal aflibercept injections for neovascular age-related macular degeneration using a treat and extend regimen
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Doi, Shinichiro
    Hirano, Masayuki
    Fujiwara, Atsushi
    Hosogi, Mika
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [20] One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration
    Yamamoto, Akiko
    Okada, Annabelle A.
    Nakayama, Makiko
    Yoshida, Yumiko
    Kobayashi, Hiroaki
    OPHTHALMOLOGICA, 2017, 237 (03) : 139 - 144
12345